Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Vitamin B2 blocks development of Alzheimerâ€™s disease in APP/PS1 transgenic mice via anti-oxidative mechanism

Rong Zhao¹, Huajun Wang¹, Chen Qiao¹, Kai Zhao²

¹Department of Pharmacy, Affiliated Hospital of Jiangsu University, Jiangsu Zhenjiang, 212000; ²School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Jiangsu Nanjing, 211198, People's Republic of China.

For correspondence:- Kai Zhao Email: xt1356@163.com

Accepted: 25 May 2018 Published: 30 June 2018

Citation: Zhao R, Wang H, Qiao C, Zhao K. Vitamin B2 blocks development of Alzheimerâ€™s disease in APP/PS1 transgenic mice via anti-oxidative mechanism. Trop J Pharm Res 2018; 17(6):1049-1054 doi: 10.4314/tjpr.v17i6.10

© 2018 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To study the effect of vitamin B2 (VB2) on the development of Alzheimer’s disease (AD).

Methods: Memory and learning abilities were assessed in amyloid precursor protein/presenilin-1 (APP/PSI) transgenic mice aged 3 months, and C57BL/6 mice, using Morris water maze test. Brain tissue levels of key antioxidant enzymes, malondialdehyde (MDA), and reactive oxygen species (ROS) were assayed using ELISA kits. Western blot assay was used to monitor the expressions of Nrf2 and Keap1 proteins.

Results: Treatment with VB 2 significantly improved cognitive function of APP/PS1 mice with respect to number of crossings, duration of stay in target quadrant (TQ), and escape latency time (p < 0.01). Moreover, VB2 also significantly reduced the levels of MDA and ROS. It also brought about significant increases in brain activities of CAT, SOD, and GSH-Px in APP/PS1 mice, relative to the control group (p < 0.01). Moreover, VB2 up-regulated Nrf2 expression but down-regulated the expression of Keap1 in brain tissue of transgenic mice.

Conclusion: These results indicate that VB2 protects the brain from ROS-induced AD damage, most likely due to its potential anti-oxidant property and activation of the Nrf2 pathway.

Keywords: Alzheimerâ€™s disease, Cognitive function, Vitamin B2, Reactive oxygen species, Superoxide oxide dismutase, Anti-oxidation